Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,989,591

« Back to Dashboard

Which drugs does patent 5,989,591 protect, and when does it expire?

Patent 5,989,591 protects RAPAMUNE and is included in one NDA. There have been two Paragraph IV challenges on Rapamune.

Protection for RAPAMUNE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,989,591

Title: Rapamycin formulations for oral administration
Abstract:This invention provides rapamycin solid dosage unit which comprises a core and a sugar overcoat, said sugar overcoat comprising rapamycin, one or more surface modifying agents, one or more sugars, and optionally one or more binders.
Inventor(s): Nagi; Arwinder S. (Thiells, NY)
Assignee: American Home Products Corporation (Madison, NJ)
Application Number:09/038,541
Patent Claim Types:
see list of patent claims
Dosage form; Process; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Pf Prism CvRAPAMUNEsirolimusTABLET;ORAL021110-004Jan 25, 2010ABRXYesNo► Subscribe► Subscribe► SubscribeY
Pf Prism CvRAPAMUNEsirolimusTABLET;ORAL021110-001Aug 25, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeY
Pf Prism CvRAPAMUNEsirolimusTABLET;ORAL021110-002Aug 22, 2002ABRXYesYes► Subscribe► Subscribe► SubscribeY
Pf Prism CvRAPAMUNEsirolimusTABLET;ORAL021110-003Feb 23, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Fish and Richardson
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: